UK markets close in 7 hours 57 minutes

Shield Therapeutics plc (STX.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
2.0399+0.0399 (+2.00%)
As of 08:00AM GMT. Market open.
Show:
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
6,187
4,467
1,519
10,387
Cost of revenue
3,416
2,470
980
1,354
Gross profit
2,771
1,997
539
9,033
Operating expenses
Research development
193
1,072
794
2,579
Selling general and administrative
28,268
24,970
17,943
5,903
Total operating expenses
24,976
27,704
20,833
11,187
Operating income or loss
-22,205
-25,707
-20,294
-2,154
Interest expense
905
327
0
0
Income before tax
-37,213
-40,082
-19,907
-1,886
Income tax expense
718
362
-229
744
Income from continuing operations
-37,931
-40,444
-19,678
-2,630
Net income
-37,931
-40,444
-19,678
-2,630
Net income available to common shareholders
-37,931
-40,444
-19,678
-2,630
Basic EPS
-0.12
-0.17
-0.10
-0.02
Diluted EPS
-0.12
-0.17
-0.10
-0.02
Basic average shares
476,634
237,906
204,409
120,682
Diluted average shares
476,634
237,906
204,409
120,682